RISK OF KIDNEY DISEASE PROGRESSION AND EFFICACY OF SGLT2 INHIBITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Moura, Filipe [1 ]
Berg, David [1 ]
Bellavia, Andrea [1 ]
Mosenzon, Ofri [1 ]
Dwyer, Jamie [1 ]
Scirica, Benjamin M. [1 ]
Wiviott, Stephen [1 ]
Bhatt, Deepak L. [1 ]
Raz, Itamar [1 ]
Feinberg, Mark William [1 ]
Morrow, David A. [1 ]
Sabatine, Marc Steven [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1493-176
引用
收藏
页码：1808 / 1808
页数：1
相关论文
共 50 条
  • [41] Effect of SGLT2 inhibition on coronary microvascular function in patients with type 2 diabetes
    Suhrs, H. E.
    Bove, K.
    Nilsson, M.
    Zander, M.
    Prescott, E.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2651 - 2651
  • [42] Alleviation of functional iron deficiency by SGLT2 inhibition in patients with type 2 diabetes
    Packer, Milton
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1143 - 1146
  • [43] SGLT2 inhibition in patients with type 2 diabetes and cardiovascular diseases: which are the benefits?
    Diaconu, Camelia
    Salmen, Teodor
    Gaman, Mihnea A.
    Bratu, Ovidiu G.
    Mischianu, Dan
    Marcu, Radu D.
    Suceveanu, Andra I.
    Costache, Raluca S.
    Stoian, Anca Pantea
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2019, 122 (01) : 16 - 21
  • [44] Efficacy and safety of SGLT2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes
    Nomiyama, Takashi
    Tanabe, Makito
    Murase, Kunitaka
    Motonaga, Ryoko
    Yanase, Toshihiko
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S93 - S93
  • [45] The Clinical Efficacy and Safety of SGLT2 Inhibitors in Japanese Patients with Type 2 Diabetes
    Tosaki, Takahiro
    Kamiya, Hideki
    Kato, Yoshiro
    Kondo, Masaki
    Nakamura, Jiro
    DIABETES, 2015, 64 : A154 - A155
  • [46] Safety and efficacy of the SGLT2 inhibitor dapagliflozin in older patients with type 2 diabetes
    Fioretto, P.
    de Bruin, T. W.
    Johnsson, E.
    Ptaszynska, A.
    Parikh, S.
    List, J. F.
    DIABETOLOGIA, 2013, 56 : S383 - S383
  • [47] Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
    Han, Eugene
    Shin, Eugene
    Kim, Gyuri
    Lee, Ji-Yeon
    Lee, Yong-Ho
    Lee, Byung-Wan
    Kang, Eun Seok
    Cha, Bong-Soo
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [48] SGLT2 inhibition and kidney protection
    Nespoux, Josselin
    Vallon, Volker
    CLINICAL SCIENCE, 2018, 132 (12) : 1329 - 1339
  • [49] SGLT2 Inhibitors slow the Progression of chronic Kidney Disease
    不详
    DIABETOLOGE, 2019, 15 (06): : 567 - 567
  • [50] Albuminuria and chronic kidney disease progression in patients with type 2 diabetes mellitus
    Kawada, Tomoyuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, : 1062 - 1063
12345